1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. GENFIT
  6. News
  7. Summary
    GNFT   FR0004163111

GENFIT

(GNFT)
  Report
Real-time Euronext Paris  -  11:36 2022-08-12 am EDT
4.460 EUR   -4.99%
08/11European ADRs Move Lower in Thursday Trading
MT
08/10European ADRs Climb Higher in Wednesday Trading
MT
08/01European ADRs Move Higher in Monday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

European ADRs Move Slightly Higher in Wednesday Trading

06/29/2022 | 11:06am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
AKARI THERAPEUTICS, PLC -0.99% 1.4851 Delayed Quote.-0.99%
ASTRAZENECA PLC 1.96% 10712 Delayed Quote.23.44%
BICYCLE THERAPEUTICS PLC 1.31% 26.25 Delayed Quote.-56.88%
CARNIVAL CORPORATION 1.71% 10.72 Delayed Quote.-46.72%
CELLECTIS S.A. -0.28% 3.614 Real-time Quote.-51.42%
ENI SPA 0.35% 11.63 Delayed Quote.-4.83%
GENFIT -4.99% 4.46 Real-time Quote.3.34%
GRIFOLS, S.A. -0.61% 13.755 Delayed Quote.-18.49%
HSBC HOLDINGS PLC 0.29% 550.5 Delayed Quote.22.70%
LONDON BRENT OIL -0.38% 97.14 Delayed Quote.27.42%
MEREO BIOPHARMA GROUP PLC 17.39% 1.35 Delayed Quote.-15.63%
MORPHOSYS AG 0.39% 23.15 Delayed Quote.-30.58%
NOVO NORDISK A/S -2.67% 770 Delayed Quote.4.76%
PEARSON PLC -0.52% 881.6 Delayed Quote.43.77%
SEQUANS COMMUNICATIONS S.A. -1.45% 3.4 Delayed Quote.-28.27%
TELEFÓNICA, S.A. -0.23% 4.273 Delayed Quote.10.93%
VERONA PHARMA PLC 15.17% 13.59 Delayed Quote.102.23%
WTI -0.42% 91.181 Delayed Quote.24.73%
All news about GENFIT
08/11European ADRs Move Lower in Thursday Trading
MT
08/10European ADRs Climb Higher in Wednesday Trading
MT
08/01European ADRs Move Higher in Monday Trading
MT
07/25European ADRs Move Higher in Monday Trading
MT
07/15European ADRs Move Higher in Friday Trading
MT
07/13European ADRs Move Higher in Wednesday Trading
MT
07/12European ADRs Move Lower in Tuesday Trading
MT
07/11GENFIT, Half-Year Report of Liquidity Contract with Credit Industriel et Commercial
AQ
07/08GENFIT : Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial - For..
PU
07/08GENFIT : Half-Year Report of Liquidity Contract with Crédit Industriel et Commercial
GL
More news
Analyst Recommendations on GENFIT
More recommendations
Financials
Sales 2022 15,0 M 15,4 M 15,4 M
Net income 2022 -46,4 M -47,6 M -47,6 M
Net cash 2022 56,2 M 57,7 M 57,7 M
P/E ratio 2022 -5,33x
Yield 2022 -
Capitalization 222 M 227 M 227 M
EV / Sales 2022 11,0x
EV / Sales 2023 4,01x
Nbr of Employees 122
Free-Float 78,7%
Chart GENFIT
Duration : Period :
GENFIT Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENFIT
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 4,46 €
Average target price 10,23 €
Spread / Average Target 129%
EPS Revisions
Managers and Directors
Pascal Prigent CEO & EVP-Marketing & Development
Thomas Baetz Chief Financial Officer
Jean-François Mouney Chairman
Dean W. Hum Chief Scientific Officer
Carol L. Addy Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
GENFIT3.34%227
MODERNA, INC.-32.60%66 966
IQVIA HOLDINGS INC.-12.88%45 846
LONZA GROUP AG-25.13%44 851
SEAGEN INC.10.05%31 380
ALNYLAM PHARMACEUTICALS, INC.37.90%28 068